Relentless Health Value

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed. Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU's Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention's (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association's (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 articles in publications including Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller's current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. 00:00 EP148: Jennifer E. Miller, PhD, Bioethics International and Creator of the Good Pharma Scorecard. 01:00 The Good Pharma Scorecard rankings for 2017. 01:40 Two 100% transparent pharma companies. 02:20 Two stats that prove that Pharma companies are improving. 03:00 Industry improvements on patient trials. 03:25 Ninety-six percent of all patient trials are available to the public. 03:45 Where there wasn't a significant improvement in disclosure in pharma.

What do physician burnout and sub-par patient portal usage have in common? It’s forgetting about how the user will react to the technology. To get what we hope to get out of a technology, we have to consider how to fulfill positive engagement and behavior change and build that right into the use case and workflow. Today I speak with Dr. Kyra Bobinet, MD MPH and CEO of EngagedIn, a neuroscience behavior design firm.

Dr. Kyra Bobinet has five words of advice on engaging people in health: be caring, authentic, and useful. As a national speaker, bestselling author and CEO-founder of engagedIN, a neuroscience behavior design firm, Kyra devotes her life to cracking the code of WHY we engage in our health. Everyday, she and her team use neuroscience to make products and communications more engaging. For this work, Kyra received the 2015 Innovator Award from Harvard where she received her Masters in Public Health. She earned her medical degree at UCSF School of Medicine. Dr. Bobinet is the author of Well Designed Life: 10 Lessons in Brain Science and Design Thinking for a Mindful, Healthy, and Purposeful Life. She has been featured by the Wall Street Journal, New York Times, Huffington Post, ExperienceLife and NPR. She has created health start-ups, blockbuster products, health apps, big data algorithms, and evidence-based programs in mind-body & metabolic medicine. A former executive at a large payer, she has designed large-scale population health management and wellness interventions that yielded ROI for Fortune 500 companies. Dr. Bobinet co-teaches patient engagement and health design with Dr. Larry Chu at Stanford School of Medicine, and studied in BJ Fogg's behavior design lab. When she's not geeking out on neuroscience, you can find her engaged in her 160-acre training center in the Santa Cruz Mountains. You can learn more at engagedin.com and changetrainingcenter.com.

Healthcare industry in 2017: It’s fragile. I’m defining fragile as the opposite of “antifragile” coined by Nassim Nicholas Taleb in his book "Antifragile," recommended to me by Don Lee, the host of the HCBiz podcast which you should listen to.

In the English language there’s no opposite of fragile. Most people would say robust, solid, or resilient, but these terms mean less fragile. You have to hit harder to break it. The opposite of fragile would be something that actually strengthens the more

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The state of health care is fragile. 00:45 Antifragile: Things That Gain from Disorder by Nassim Nicholas 02:20 How easy it is for healthcare systems to break down. 02:40 "You can't domesticate disorder, volatility, or uncertainty." 03:15 The requirements of being an antifragile organization. 03:30 "Does everyone on the team understand the end game?" 04:45 Balancing people and processes. 05:25 "There is always judgement involved." 06:30 Overlap and quality control. 09:10 Allow for small mistakes. 11:45 The need for a feedback group. 14:15 Iatrogenic - relating to an illness caused by medical examination or treatment. 15:20 How rapid scaling slows down the ability to become antifragile. 17:10 Testing if you're doing something for the wrong reasons. 18:00 "What does the healthy business look like?" 18:20 How oligopolies make health care more fragile.

Ross Bjella, MBA is the founder and CEO of Alithias, a patient advocacy and population health analytics company serving self-insured employers, insurance companies, networks, and third party administrators.  “Alithias” means “the truth” in Greek and currently has >60,000 lives with access to the platform.  Ross has held senior management positions in the health care industry, including pharmaceuticals, biotech, and medical devices. Prior to Alithias, Ross served as the CEO of DDN, a leading business process outsourcer for pharma and biotech companies. Ross still consults with pharma companies about 3PL selection and resolving and supply chain issues from time to time.  He has a degree in Biology from the University of Minnesota and a MBA from the University of Southern California.

You can learn more at alithias.com or by emailing Ross at [email protected], or following Ross on twitter @rossbjella.

Ross Bjella, MBA is the founder and CEO of Alithias, a patient advocacy and population health analytics company serving self-insured employers, insurance companies, networks, and third party administrators. "Alithias" means "the truth" in Greek and currently has >60,000 lives with access to the platform. Ross has held senior management positions in the health care industry, including pharmaceuticals, biotech, and medical devices. Prior to Alithias, Ross served as the CEO of DDN, a leading business process outsourcer for pharma and biotech companies. Ross still consults with pharma companies about 3PL selection and resolving and supply chain issues from time to time. He has a degree in Biology from the University of Minnesota and a MBA from the University of Southern California. You can learn more at alithias.com or by emailing Ross at [email protected], or following Ross on twitter @rossbjella.

Pramod John is team leader of Vivio Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space.

The Vivio Health plan solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process.

Prior to Vivio Health, Pramod was founder of Oration PBC (acquired by PokitDok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician’s office and providing real-time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world’s largest health care company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize health care delivery systems, infrastructure, and supply chains.

Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMware. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell).

Pramod earned his PhD in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization, and 3Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX.

You can learn more at www.viviohealth.com.

Pramod John is team leader of Vivio Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. The Vivio Health plan solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to Vivio Health, Pramod was founder of Oration PBC (acquired by PokitDok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real-time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest health care company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize health care delivery systems, infrastructure, and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMware. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his PhD in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization, and 3Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Blockchain is the tech behind bitcoin. It’s sometimes called a distributed ledger, which is a way of saying that everybody in the blockchain network has a ledger on their computer, and when a transaction occurs, every copy gets updated. If everyone can see the transaction, then effectively we have interoperability without having interoperability. If I have to interoperate with someone, I have to trust them with a hole through my firewall. With blockchain, all I need to trust is the blockchain.